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A B S T R A C T
 
Atypical fast-growing Mycobacterium species are usually identified after laser-assisted in situ 
keratomileusis, cosmetic surgeries, and catheter-related, pulmonary or soft tissue infections. 
We herein present the case of a 56-year-old man with purulent discharge, redness, and 
foreign body sensation in his left eye. He underwent two surgeries that partially controlled 
the infection but were not curative. Corneal transplantation was performed, and a biopsy 
of the excised cornea indicated Mycobacterium aurum infection, which was confirmed by 
polymerase chain reaction-restriction fragment length polymorphism analysis. This appears 
to be the first documented case of keratitis attributable to the non-tuberculous mycobateria 
M. aurum. The intractable extra-ocular progression of the disease in the absence of general 
signs or symptoms was notable. We suggest considering non-tuberculous mycobacteria 
among the probable causes of complicated keratitis or keratitis that does not respond to 
drug treatment, especially in regions where tuberculosis is endemic. 
Introduction
Ocular tuberculosis (TB) is a complex clinical entity that 
presents diagnostic and management challenges for both 
ophthalmologists and infectious disease specialists, as 
well as for public health workers. Depending on its clinical 
manifestations, ocular TB can involve intraocular or extraocular 
tissues and structures. Intraocular TB is more common than 
the extraocular form,1 and its diagnosis is more complicated.2 
Interstitial keratitis, which indicates the spread of infection to 
the corneal stroma, is one of the miscellaneous presentations 
of extraocular TB. Scleritis (necrotizing or non-necrotizing) can 
also occur simultaneously.3
Mycobacterium aurum is a Gram-positive, acid-fast bacterium 
which is fast-growing and mostly non-infectious.4 It belongs 
to the atypical category of mycobacteria that do not cause TB 
or Hansen’s disease. This species, also called non-tuberculous 
mycobacteria (NTM), is also known as environmental myco-
bacteria or mycobacteria other than tuberculosis-causing. In 
contrast to typical TB infections, this atypical mycobacterial 
infection is non-communicable. The species is present in 
the environment, especially in wet soils, rivers, lakes, and 
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swamps. Rapidly growing mycobacteria other than M. aurum 
include Mycobacterium fortuitum, Mycobacterium chelonae, 
Mycobacterium abscessus and Mycobacterium neoaurum. Except for 
M. aurum, which is usually commensal, other species are 
pathogenic in humans, and can cause cellulitis, osteomyelitis, 
wound infections, and central catheter-related infections.5,6
Non-tuberculous mycobacterial keratitis was first reported 
by Turner and Stinson in 1965.7 Since then, the number of 
cases recorded has increased. In 2002, there was an outbreak 
of M. chelonae keratitis associated with laser-assisted in situ 
keratomileusis. Further research showed that this type of 
surgery could be a risk factor for the development of NTM 
keratitis.8 Despite the increase in the number of documented 
cases since the first description in 1965, NTM keratitis 
continues to pose challenges in terms of diagnosis and 
management.
To the best of our knowledge, this is the first documented 
case of keratitis caused by the NTM M. aurum. The bacterium 
was responsible for keratitis as well as the troublesomely 
silent extra-ocular progression of the disease in the absence 
of general signs or symptoms.
The Institutional Review Board and the Ethics Committee 
of Shiraz University of Medical Sciences approved the decision 
to report this novel case. The patient also gave his written 
informed consent.
Case presentation
The patient was a 56-year-old man who presented with a 
chief complaint of left eye redness, foreign body sensation and 
tearing. Based on an initial diagnosis of viral conjunctivitis, 
a topical corticosteroid was prescribed. One month later, the 
patient returned with aggravated symptoms and purulent 
discharge, eyelid swelling, photophobia, and corneal infiltration. 
He was diagnosed as having secondary bacterial keratitis and 
was treated with moxifloxacin and sulfacetamide. In the course 
of follow-up, during the subsequent two months, the cornea did 
not heal and the patient developed progressively blurred vision. 
At this time a confocal scan was negative for fungal or 
acanthamoeba infection. Superficial keratectomy was done 
for diagnostic and therapeutic purposes. The pathology and 
microbiology reports were negative. The complete preoperative 
laboratory work-up included complete blood cell count, fasting 
blood sugar, blood urea nitrogen, serum creatinine, sodium, 
potassium, phosphate, and calcium, liver function tests, lipid 
profiles, urinalysis, and stool analysis for occult blood, ova, 
and parasites. All results were normal except for an elevated 
lymphocyte count (45.8% whole blood cells, equivalent to 
4000/µL) slightly elevated uric acid (8.9 mg/dL), and low-density 
lipoprotein (133 mg/dL). Blood cultures were performed with 
blood samples from three different sites, but no organisms 
grew. Plain chest X-ray revealed no abnormal findings. 
Because of worsening infective keratitis and invasion 
of deeper layers of the cornea (Fig. 1A), a conjunctival 
flap procedure was done. However, after one month the flap 
became necrotic and retracted, and was therefore debrided. 
A second corneal biopsy was obtained, and this time the 
pathology report indicated mycobacterial keratitis with 
positive acid-fast staining. As a result of this diagnosis, 
topical and oral moxifloxacin and azithromycin were started. 
However, because the infection progressed and early corneal 
melting appeared, we decided to perform corneal collagen 
cross-linking (CXL) with riboflavin and ultraviolet light. 
Curative CXL was done with two major goals: to stop and 
resolve the infective process, and to slow corneal melting. 
After 1-2 weeks we observed partial resolution of the infection. 
However, due to progression of the residual infection and dense 
opacification of the cornea, we decided to perform corneal graft 
transplantation with the penetrating keratoplasty method. 
A final biopsy of the excised cornea was sent to the national 
TB reference center in Tehran, Iran for polymerase chain 
reaction–restriction fragment length polymorphism (PCR-
RFLP) assay, which confirmed M. aurum as the causal agent. 
Throughout the course of the infection, the patient was afebrile 
and physical examination was normal. At the time of writing, 
the patient is well (Fig. 1B) with satisfactory slit lamp findings, 
and a single-eye visual acuity of 20/400.
Fig. 1 - Slit lamp findings. (A) One month after initial presentation, worsening infective keratitis and invasion of deeper 
layers of the cornea were accompanied by dense infiltration. (B) After corneal transplantation, the clear corneal graft was 
accompanied by a nuclear cataract due to chronic inflammation.
(A) (B)
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Identification of non-tuberculosis mycobacteria by PCR-RFLP
The mycobacterial species was identified by molecular 
methods. DNA was extracted from the eye biopsy sample 
with a standard method.9 Briefly, 1 mL of decontaminated 
sample was heat-killed at 90°C for 30 min. The sample was 
lysed in digestion buffer (500 mM Tris-HCl, pH 9.0, 20 mM 
EDTA, 10 mM NaCl, 1% SDS). The DNA was purified by 
phenol and chloroform/isoamyl alcohol (24:1 vol/vol) and 
was precipitated by isopropanol. The pellet was washed 
in 70% ethanol and dried at room temperature. It was 
then resuspended in TE buffer (50 mM Tris, 100 mM EDTA, 
pH 8.0) and stored at 4°C.
A nested PCR method was used to amplify a 440-bp 
fragment of the 65-kDa heat shock protein gene. The 
first PCR reactions (50 μL) contained target DNA (10 ng), 
16 pmol of the primers tb15 (5′-CGT AYG ACG AAG AGG 
CCCGT-3′) and tb17 (5′-WAS GGR TCC TCS AGG ACSGC-3′), 
0.2 mM dNTP (Fermantase), 2.5 U Taq DNA polymerase 
(Cinagene), 2 mM MgCl2, and 5 μL 10× buffer. The reaction 
was subjected to amplification for 5 min at 95°C for initial 
denaturation, 20 s at 95°C, 1 min at 60°C, 40 s at 72°C for 
30 cycles, followed by 5 min of extension at 72°C.
For the second round of PCR, the reaction mixture 
(50 μL) contained 2 μL of the target PCR product, 16 pmol 
of the primers Tbll (5-ACC AAC GAT GGT GTG TCC AT) 
and Tb12 (5-CTT GTC GAA CCG CAT ACC CT), 0.2 mM 
dNTP (Fermantase), 2.5 UTaq DNA polymerase (Cinagene), 
2 mM MgCl2, and 5 μL 10× buffer. After 5 min at 95°C for 
initial denaturation, the reaction was subjected to 40 cycles 
of amplification for 30 s at 94°C, 1 min at 56°C, 40 s at 
72°C, followed by 5 min of extension at 72°C. The PCR 
products were then run on 2% agarose gels made up in 
0.5× Tris-Borate-EDTA buffer with ethidium bromide, and 
examined for the presence of the bands of interest. 
The  ampl i f ied  f ragment  was  d iges ted  by  two 
endonuclease enzymes (HaeIII and BstEII). For BstEII 
digestion, 10 μL of the PCR product were added directly to 
a mixture containing 1 μL of enzyme, 2 μL of restriction 
buffer (5× buffer B), and 18 μL water, and the mixture is 
incubated for 16 h at 37°C. Similarly, 10 μL of the product 
was digested at 37°C in a solution containing HaeIII enzyme, 
the corresponding buffer (5× buffer R), and water.10
To evaluate the restriction patterns, after digestion, 5 μL 
of gel loading buffer (0.25% bromophenol blue, 40% sucrose 
in water) were added to 15 μL of the digested samples. The 
mixture was loaded onto a 10% acrylamide-bisacrylamide 
gel. Fragments were visualized by ethidium bromide 
staining under ultraviolet light. The patterns found after 
digestion with HaeIII were four bands of 135, 115, 70, and 
60 bp. The digestion product pattern with BstEII was a 
single 440-bp band. Comparison of the patterns with 
standard strains from the Pasteur Institute of France 
(http://app.chuv.ch/prasite/index.html) confirmed that the 
strain isolated was M. aurum type 2 (Fig. 2).
Discussion
Mycobacterium aurum was first described by Tsukamura in 
1996.11 Since then, only three cases of infection by this type 
of Mycobacterium have been published. The first one (1998) 
was a 60-year-old man being treated for T-cell non-Hodgkin’s 
lymphoma. He presented with fever, chills and weight loss 
of three weeks’ duration, and catheter-related bacteraemia 
by M. aurum was found to be responsible.12 The second one 
(2003) was a 5-year-old boy with metastatic Wilms’ tumor of 
the right kidney, who was admitted with a 1-day history 
of fever, preceded by a 27-week course of chemotherapy. After 
a prolonged search, the source of infection was found to be a 
Broviac catheter.5 The third case (2008) reported to date was 
a 25-year-old man with idiopathic bilateral uveitis treated 
with intravenous corticosteroids and infliximab. A few days 
after the treatment started, he developed fever and weakness. 
In the two previous cases, M. aurum was found in blood 
cultures, but in the last case blood cultures were negative and 
M. aurum was detected by solid-organ lung biopsy.13
Fig. 2 - The result of PCR restriction enzyme analysis  
for the 65-kDa heat shock protein gene.  
Lane 1: 100-bp marker (M). Lane 2: Digestion product 
with HaeIII: four bands of 135, 115, 70 and 60 bp.  
Lane 3: Digestion product with BstEII: a single 440-bp 
band was seen. Comparison of the bands with  
standard strains from the Pasteur Institute of France 
(http://app.chuv.ch/prasite/index.html) confirmed  
that the strain isolated from our patients was 
Mycobacterium aurum type 2.
M
100bp
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The bacterium can be identified via two methods: 
biochemical analysis and molecular-based methods. The 
first, which is conventionally used, depends on the diagnosis 
and isolation of mycobacteria and subsequent phenotypic or 
whole-cell fatty acid analysis. Molecular-based analysis is the 
gold standard method, particularly in unidentified cases.14 Gene 
sequencing is the best molecular-based method, which in some 
cases leads to reclassification of previously diagnosed M. aurum 
to other mycobacterial species.15,16 But PRA (PCR-RFLP Analysis) 
method is also one of the most reliable techniques, especially for 
identification of mycobacterial species, and its efficacy has been 
well-established and well-proven.17-21 We used this method by 
means of 65-kDa heat shock protein on two samples and both 
results definitively confirmed the presence of M. aurum.
In comparison to previous cases, our patient’s general 
condition was good and no signs or symptoms were detected, 
even on chest X-ray. He was not immunocompromised in any 
way, but was well and had no underlying disease (including 
diabetes or malignancy). He was not taking immunosuppressants, 
and did not have an arterial or venous catheter. The only factor 
that may have made our patient prone to this infection was 
occupational exposure, since the air at his workplace contained 
large amounts of dust and soil particles in suspension. The 
patient also mentioned a minor trauma to his eye.
Infection by M. aurum is a potential threat in the 
management of critical cases of ocular TB even in patients 
with no predisposing factors. Early diagnosis and prompt 
treatment may be sight-saving. We suggest considering NTM 
among the probable causes of complicated keratitis, and 
as a possible cause in patients who fail to respond to drug 
treatment, especially in regions where TB is endemic.22,23 
We also recommend additional laboratory tests when the type 
of Mycobacterium remains unidentified.
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